#United States #Minneapolis #diabetes management #Assure® Titanium #ARKRAY

ARKRAY Introduces Assure® Titanium BGMS for Long-Term Care

In a significant step forward for diabetes management, ARKRAY, a renowned leader in clinical diagnostics, has launched the Assure® Titanium Blood Glucose Monitoring System (BGMS). This state-of-the-art system targets post-acute and long-term care environments, aiming to enhance diabetes protocols within skilled nursing facilities, endocrinology clinics, and other relevant healthcare settings across the nation.

Elevating Standards in Diabetes Management

This innovative system has been clinically validated in multiple settings, including long-term care and skilled nursing facilities. It has received FDA clearance based on stringent guidelines, guaranteeing its accuracy, reliability, and robust performance in real-world applications. Such endorsements come as a result of thorough clinical studies that confirm the system's effectiveness in these specialized environments.

One of the standout features of the Assure® Titanium BGMS is its 24-hour quality control (QC) lockout. This functionality enforces mandatory daily quality control testing, ensuring that glucose readings are produced solely from verified devices. This not only adheres to best clinical practices but also significantly reduces the potential for errors, all while helping facilities maintain regulatory compliance.

A Commitment to Healthcare Excellence

Toshio Serizawa, the COO of ARKRAY USA, emphasizes that “Assure® Titanium represents a significant advancement in point-of-care glucose testing for long-term care.” This reflects their unwavering dedication to delivering reliable, clinically valid tools that aid healthcare settings in meeting both regulatory standards and patient care expectations.

By integrating compliance features and safeguards that enhance accuracy and efficiency, the Assure® Titanium BGMS not only supports caregivers but also ensures the health and safety of residents. Such enhancements significantly strengthen daily diabetes management among patients in post-acute settings.

Seamless Integration into Existing Workflows

The launch of the Assure® Titanium BGMS is bolstered by ARKRAY USA's comprehensive training and implementation services, which are designed to ensure smooth integration into current healthcare workflows. By providing necessary training, facilities can expedite the process of adapting to this advanced system, ultimately leading to improved health outcomes for patients.

For more information or to schedule a demo, visit arkrayusa.com or reach out to your local ARKRAY representative.

About ARKRAY USA, Inc.

Founded in Kyoto, Japan, ARKRAY USA, Inc. operates as a prominent division of ARKRAY. The company has over fifty years of experience pioneering healthcare products that address the needs of patients worldwide. With operations in over 80 countries and strong market positioning in diabetes management within professional healthcare contexts in the U.S., ARKRAY continues its legacy of contributing to global health and well-being. For additional details, visit www.arkrayusa.com.